Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodesBMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1226 (Published 17 May 2022) Cite this as: BMJ 2022;377:o1226
- Jacqui Wise
A magnetic liquid tracer and a handheld sensing probe are now recommended as an option to help surgeons establish whether breast cancer has spread.
Hospitals with limited or no access to a radiopharmacy department could particularly benefit from the Magtrace and Sentimag system, said draft guidance from the National Institute for Health and Care Excellence (NICE).1 The new technology could also reduce the reliance on having radioactive isotopes shipped into the country, meaning that patients may have to travel less for biopsies.
Magtrace is a non-radioactive, dark brown liquid that is both a magnetic …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.